Bacterial Nosocomial Infections: Multidrug Resistance as a Trigger for the Development of Novel Antimicrobials

• Main Authors: Sílvia A. Sousa, Joana R. Feliciano, Tiago Pita, Catarina F. Soeiro, Beatriz L. Mendes, Luis G. Alves, Jorge H. Leitão
• Format: Article
• Language: English
• Published: MDPI AG 2021-08-01
• Series: Antibiotics
• Subjects: nosocomial infections; multidrug-resistant (MDR) bacteria; novel antimicrobial agents; drug repurposing; metal-based complexes; antimicrobial peptides
• Online Access: https://www.mdpi.com/2079-6382/10/8/942

Nosocomial bacterial infections are associated with high morbidity and mortality, posing a huge burden to healthcare systems worldwide. The ongoing COVID-19 pandemic, with the raised hospitalization of patients and the increased use of antimicrobial agents, boosted the emergence of difficult-to-treat multidrug-resistant (MDR) bacteria in hospital settings. Therefore, current available antibiotic treatments often have limited or no efficacy against nosocomial bacterial infections, and novel therapeutic approaches need to be considered. In this review, we analyze current antibacterial alternatives under investigation, focusing on metal-based complexes, antimicrobial peptides, and antisense antimicrobial therapeutics. The association of new compounds with older, commercially available antibiotics and the repurposing of existing drugs are also revised in this work.